OtherArticle
Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug Interactions Caused by CYP3A4 Induction
Sharon L. Ripp, Jessica B. Mills, Odette A. Fahmi, Kristen A. Trevena, Jennifer L. Liras, Tristan S. Maurer and Sonia M. de Morais
Drug Metabolism and Disposition July 12, 2006, DOI: https://doi.org/10.1124/dmd.106.010132
Sharon L. Ripp
Jessica B. Mills
Odette A. Fahmi
Kristen A. Trevena
Jennifer L. Liras
Tristan S. Maurer
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug Interactions Caused by CYP3A4 Induction
Sharon L. Ripp, Jessica B. Mills, Odette A. Fahmi, Kristen A. Trevena, Jennifer L. Liras, Tristan S. Maurer and Sonia M. de Morais
Drug Metabolism and Disposition July 12, 2006, DOI: https://doi.org/10.1124/dmd.106.010132
OtherArticle
Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug Interactions Caused by CYP3A4 Induction
Sharon L. Ripp, Jessica B. Mills, Odette A. Fahmi, Kristen A. Trevena, Jennifer L. Liras, Tristan S. Maurer and Sonia M. de Morais
Drug Metabolism and Disposition July 12, 2006, DOI: https://doi.org/10.1124/dmd.106.010132
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement